Innovative Solutions for Brain Disorders

Claim My Business
Security Type
Common Stock
Min Investment
Bridgewater, NJ
Offering Date
November 09, 2021
Expected Close Date
January 27, 2023
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

We are Neurotez - a company passionately devoted to getting a meaningful treatment to cure or even prevent the onset and progression of Alzheimer’s disease.

Key Deal Facts

Currently there is an FDA approved drug on the market, but despite the limited evidence for its efficacy, it's available for $56,000 per patient per year - creating a $366 billion market in the US alone.
Drug as a biologic will get 12 years of market exclusivity from the US.
Data from pre-clinical studies demonstrating efficacy as a disease modification entity.

Management Team / Advisory Board Bios

Nikolaos Tezapsidis, PhD, President, CEO and Chairman of the Board
PhD in Biochemistry at the University of Sussex, UK
Founder of Neurotez Inc.
18+ years of biomedical research
Two awards from the Alzheimer's Association, USA
Awards from Welcome Trust and Science and Engineering Council, Uk, 50 publications

J. Wesson Ashford, Chief Medical Officer
MD and PhD in Neuroscience from UCLA
100+ publications on Alzheimer's disease
Senior Research Scientist at the Stanford/VA Aging Clinical Research Center and Alzheimer's Center

Jukka Karjalainen, Chief Operations Officer
25+ years of pharma experience in US, Canada, and Europe
Authored 55 original publications in top-rated international medical journals, Member of International Science Advisory Board
Amount Raised : $15,952
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter